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Members of the family Rhabdoviridae have been assigned to eight genera but many remain unassigned.
Rhabdoviruses have a remarkably diverse host range that includes terrestrial and marine animals,
invertebrates and plants. Transmission of some rhabdoviruses often requires an arthropod vector, such as
mosquitoes, midges, sandﬂies, ticks, aphids and leafhoppers, in which they replicate. Herein we
characterize Niakha virus (NIAV), a previously uncharacterized rhabdovirus isolated from phebotomine
sandﬂies in Senegal. Analysis of the 11,124 nt genome sequence indicates that it encodes the ﬁve
common rhabdovirus proteins with alternative ORFs in the M, G and L genes. Phylogenetic analysis of the
L protein indicate that NIAV′s closest relative is Oak Vale rhabdovirus, although in this analysis NIAV is
still so phylogenetically distinct that it might be classiﬁed as distinct from the eight currently recognized
Rhabdoviridae genera. This observation highlights the vast, and yet not fully recognized diversity, of this
family.
& 2013 Elsevier Inc. All rights reserved.Introduction
Phlebotomine sandﬂies are small hematophagous insects that
serve as vectors of protozoa, bacteria, and a diverse group of
vertebrate viruses, including members of the families Rhabdoviridae,
Bunyaviridae, Flaviviridae and Reoviridae (Karabatsos, 1985; Shope
and Tesh, 1987; Tesh, 1988). Of the rhabdoviruses associated with
sandﬂies, most are members of the genus Vesiculovirus, including
such human and veterinary pathogens as Chandipura (CHPV),
Vesicular stomatitis Indiana (VSIV) and Vesicular stomatitis New
Jersey (VSNJV) viruses (Karabatsos, 1985; Shope and Tesh, 1987).ll rights reserved.
Medical Branch, Center for
Department of Pathology,
enter for Tropical Diseases,
eston, TX 77555-0609, USA.In this communication we report the characterization of a novel
virus (DakArD 88909), which we designate as Niakha virus (NIAV)
after the site where it was ﬁrst isolated in Senegal. NIAV was
isolated from a pool of 200 sandﬂies collected in front of a termite
hill located near a seasonal ground pool in Niakha in March 1992.
This location is situated 4 kmwest of the village of Barkedji, within
the Sahelian shrubby savannah ecotype, Senegal (Fontenille et al.,
1994). This virus was sensitive to chloroform treatment and was
isolated after 2 passages in newborn mice, which were paralyzed
by day 2 post infection (p.i.). According to Fontenille et al. (1994)
complement ﬁxation (CF) suggested that this isolate was different
from 80 other African arboviruses registered at the time at the
World Health Organization Collaborating Center for Reference and
Research on Arboviruses (CRORA) located at the Institut Pasteur de
Dakar, as well as a couple of Phleboviruses isolated in Africa at the
time. To date, there is no evidence that NIAV infection leads to
human disease. Here we show that NIAV is a new rhabdovirus
species with a distinctive morphology and genome organization
that it is distantly related to Oak Vale virus isolated in Australia.
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Growth in cell culture
NIAV produced marked cytopathic effect (CPE) in BHK (baby
hamster kidney), Vero E6 (African green monkey kidney) and
C6/36 (Aedes albopictus) cells, 4, 8 and 7 days after inoculation,
respectively, but it did not produce CPE in PP-9 (Phlebotomus
papatasi) cells. Ultrathin-section electron micrographs of the virus
in infected BHK and PP-9 cells are shown in Fig. 1A–F, respectively.
Virus morphology
Virus particles were regularly found packed in stacks in
expansions of perinuclear space and in cisterns of granular
endoplasmic reticulum of BHK cells (Fig. 1A–C). They were
∼45 nm in diameter and 180–200 nm in length. The accumulation
of NIAV particles in intracellular vesicles is not unusual for
rhabdoviruses. In fact, particles stacked in intracellular vesicles
were reported in the ﬁrst description of VSV morphogenesis in
1968 (Hackett et al., 1968). While mature virions of animal
rhabdoviruses exit the cell by a budding process through the cell
membrane, it is possible that the observed stacks of NIAV
will be transported through these membrane bound vesicles
(e.g. endoplasmic reticulum) to the cell surface for budding.Fig. 1. Ultrastructure of NIAV strain DakArD 88909 in baby hamster kidney (BHK) ((A
particles in an expansion of perinuclear space (arrows) of an infected BHK cell. Ribosom
virus particles in a cistern of granular endoplasmic reticulum of BHK cell; (C) Cross se
(D) Virions budding from the surface of an infected BHK cells; (E) Virus particles in sp
350 nm long. Arrow indicates a virus budding from the host cell membrane; (F) AggregVirions observed budding from the BHK cell surfaces (Fig. 1D),
exhibited a two-rounded end bullet-like particle morphology of
∼40 nm in diameter, rather than the classic one-rounded end
bullet-like rhabdovirus morphology. A similar particle morphology
was observed with Oak Vale virus (OVRV) (Gubala, 2009), and
Tupaia virus (Kurz et al., 1986). In ultrathin sections of PP-9 cells,
virus particles ∼50 nm in diameter and up to 350 nm long were
observed mostly at the cell surface, where they could be seen
budding (Fig. 1E). Aggregates of tightly packed virions were also
observed in the extracellular space of the sandﬂy cells (Fig. 1F).
Antigenic relationships
Complement ﬁxation (CF) tests were conducted using NIAV mouse
brain antigen and hyperimmune ascitic ﬂuid (MIAF) and antisera
against 23 other rhabdoviruses, including 19 viruses isolated pre-
viously in Africa (Table 1). NIAV MIAF reacted only with the homo-
logous (NIAV) antigen at a dilution of 1:512. No CF cross-reactions
were detected with any of the other 23 rhabdoviruses.
Phylogenetic analysis
The ML tree of 45 rhabdovirus L protein sequences is shown in
Fig. 2. Members of the Cytorhabdovirus, Novirhabdovirus and Nucleor-
habdovirus genera are highly divergent from all other rhabdoviruses)–(D)) and sandﬂy (Phlebotomus papatasi) PP-9 ((E)–(F)) cells. (A) Stacks of virus
es are decorating the outer surface of its membrane. N¼cell nucleus; (B) A stack of
ction of a stack of virus particles in a cistern of granular endoplasmic reticulum;
ace between infected PP-9 cells. They are ∼50 nm in diameter, virion at the top is
ate of virus particles in an extracellular space of infected PP-9 cells. Bars¼1 mm.
Table 1
Antigenic relationship by complement ﬁxation (CF) test of NIAV with other representative members of the family Rhabdoviridae.
Rhabdoviridae Antigen Virus (strain) NIAV antibodyn Homologous antibody
Vesiculovirus genus
Species in the genus Chandipura (DakArD 1125) 0 512
Isfahan (91026-167) 0 64
VSV Indiana (VP98F) 0 512
VSV New Jersey (PA AN 3566) 0 64
Related viruses not yet approved
as vesiculovirus species
Boteke (DakArB 1077) 0 ≥256
Perinet (DakArMg 802) 0 512
Other animal rhabdoviruses not
yet approved as species
Bangoran (DakArB 2053) 0 256
Bimbo (DakAnB 1054) 0 ≥256
Durham (CC 228-05) 0 512
Garba (DakAnB 439) 0 1024
Gossas (DakAnD 401) 0 512
Kamese (MP 6186) 0 ≥256
Keuraliba (DakAnD 5314) 0 1024
Kolente (DakArK7292) 0 1024
Kolongo (DakArB 1094d) 0 8
Le Dantec (Dak SH 763) 0 ≥1024
Mossuril (SA Ar 1995) 0 32
Nasoule (DakAnB 4289) 0 ≥256
Nkolbisson (YM 31-65) 0 ≥256
Ouango (DakArB 2053) 0 64
Yata (DakArB 2181) 0 256
Niakha (DakArD 88909) 512 –
n CF titer expressed as reciprocal of highest positive antibody dilution, 0¼o8.
Fig. 2. ML phylogenetic tree of 45 rhabdovirus L protein sequences. The position of NIAV is shaded and bootstrap support values (470%) are shown for key nodes. All
horizontal branch lengths are drawn to a scale of amino acid substitutions per site, and the tree is rooted in the position observed in a broader analysis of the Rhabdoviridae
(i.e. including members of the Cytorhabdovirus, Novirhabdovirus and Nucleorhabdovirus; not shown). (n) Genera proposed but not yet formally approved by the International
Committee on Taxonomy of Viruses (ICTV).
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Fig. 3. Organisation of NIAV single-strand negative-sense RNA genome.
(A). Schematic representation of the genome organisation of NIAV and several
distantly related rhabdoviruses (Oak Vale virus, OVRV Genbank JF705877; Durham
virus, DURV, Genbank FJ952155; Tupaia virus, TUPV, Genbank NC007020; and
Moussa virus, MOUV, Genbank FJ985749). Block arrows indicate the location of
long ORFs, including consecutive and overlapping ORFs (light shading). The DURV
genome organisation is based on the available partial sequence. Several alternative
long ORFs in the OVRV genome have not been reported previously. (B). NIAV coding
regions, designated ORFs and putative transcription regulatory sequences.
(C). Sequences of NIAV gene junctions illustrating potential transcription initiation
sequences (shaded), transcription termination/polyadenylation sequences (solid
underlined) and initiation and termination codons of the ﬂanking ORFs (dotted
underline). Alternative initiation codons at the G–L gene junction are for the U3 and
L ORFs in different reading frames.
N. Vasilakis et al. / Virology 444 (2013) 80–89 83including NIAV and hence were excluded from this analysis to
maximize phylogenetic resolution with respect to NIAV. Notably, in
this analysis NIAV falls as a distinct lineage within the major group of
animal rhabdoviruses, which includes a number of recognized and
proposed viral genera. While NIAV is most closely related to Oak Vale
rhabdovirus (OVRV) in this phylogeny, and with relatively good
bootstrap support (75%), these viruses are still relatively divergent,
indicative of a long evolutionary separation. Although a lack of
bootstrap support at the base of this part of the tree prevents ﬁne-
scale resolution of the evolutionary history of NIAV, its divergent
phylogenetic position, combined with its lack of cross-reaction to
other rhabdoviruses in CF tests (see above), strongly suggests that it
represents a novel virus species. Indeed, NIAV is clearly more
phylogenetically distinct than a number of recognized species within
the Rhabdoviridae.
Genome organization and assembly
A sequencing library was prepared from the sample RNA
extracted from BHK infected cells, using an Illumina TruSeq RNA
v2 kit following the manufacturer′s protocol. The sample was
sequenced on a HiSeq 1000 using the 250 paired-end protocol.
Reads in fastq format were quality-ﬁltered, and any adapter
sequences were removed, using Trimmomatic (Lohse et al., 2012)
software. The de novo assembly program ABySS (Simpson et al.,
2009) was used to assemble the reads into contigs, using several
different sets of reads, and k values from 20 to 40. A nearly full-
length contig was obtained from a 250,000 read random subset of
the total reads that included non-viral and viral reads and a k
value of 25. Reads were mapped back to the contig using bowtie 2
(Langmead and Salzberg, 2012), and visualized with the Integrated
Genomics Viewer (Robinson et al., 2011) to verify that the
assembled contig was correct. About 5% of the reads in the sample
mapped to the viral contig, resulting in about 350,000 reads
mapped out of about 7.6 million total.
The 11,124 nt NIAV genome comprises partially complementary
3′- and 5′-terminal non-coding regions (approximately 57 nt and
54 nt, respectively) and ﬁve coding regions (genes), each bounded
by putative transcriptional regulatory sequences (Fig. 3A–C).
The transcription termination/polyadenylation (TTP) signals
([G/U]UAC[U]7) are relatively conserved and similar to those of
most other animal rhabdoviruses (Fig. 3B). However, transcription
initiation (TI) sequences, although also similar to those of many
other rhabdoviruses, are more cryptic and apparently quite vari-
able, with only the ﬁrst three nucleotides (UUG) fully conserved
and alternative initiation sites appear to be available in the ﬁrst
three coding regions. Uniquely among those rhabdoviruses
sequenced to date, the gene 2 TI sequence appears to be located
upstream of the gene 1 TTP sequence to create an overlap that is
more commonly associated with rhabdovirus L genes. Gene 1 con-
tains a single ORF encoding a 426 amino acid (aa) polypeptide
(47.4 kDa) with identiﬁable sequence identity to the N proteins of
other rhabdoviruses. Gene 2 also contains a single ORF encoding a
297-aa acidic polypeptide (33.6 kDa; pI 4.78) that exhibits the
highest sequence similarity to the TUPV P protein and a similar
size and charge distribution to the P proteins of other animal
rhabdoviruses. Gene 3 contains two consecutive ORFs: the ﬁrst ORF
encodes a 187-aa polypeptide (20 kDa) that aligns with the M
proteins of other animal rhabdoviruses; and the second ORF (U1)
encodes an 81-aa polypeptide (9.4 kDa) that shows no signiﬁcant
sequence identity with any other known protein and is of unknown
function. The termination codon of the M ORF and the initiation
codon of the U1 ORF overlap by a single nucleotide, resulting in a -1
shift in reading frames. Gene 4 encodes the 511-aa NIAV G protein.
It displays the common features of rhabdovirus G proteins which
are class I transmembrane glycoproteins containing an N-terminalsignal peptide, a C-terminal transmembrane domain, multiple N-
glycosylation sites and a set of highly conserved cysteine residues
(Fig. 4). Multiple sequence alignments indicated that the NIAV G
protein is most similar to those of TUPV and DURV with which it
shares ten of the twelve cysteine residues (C1 to CXII) that are highly
conserved amongst animal rhabdoviruses (Walker and Kongsuwan,
1999) (Fig. 4A). Unlike those rhabdoviruses analyzed to date, the
NIAV contains an alternative ORF in the N-terminal region of the G
gene. ORF U2 encodes a small 97-aa hydrophobic protein (10.8 kDa)
with two predicted transmembrane domains and the predicted
topology of a class IVb transmembrane protein with a C-terminal
ectodomain and no predicted N-glycosylation sites (Fig. 4B). The
function of the NIAV putative U2 is presently unknown.
Signiﬁcantly, NIAV shared with DURV and TUPV (but not OVRV)
10 of the 12 cysteine residues that are highly conserved among
animal rhabdoviruses. Each of these viruses lacks the CVIII–CX
disulphide bridge which, in the VSIV G protein, links the second
segment of pleckstrin homology domain (domain III) to α helix C
which sits just before the junction with the fusion domain
(domain IV) (Roche et al., 2006, 2007). The NIAV G protein does
have an additional pair of cysteine residues downstream of CXII in
the lateral domain (domain I). These cysteine residues, which are
likely to form a disulphide bridge, are absent from the tupavirus G
Fig. 4. Deduced amino sequences of polypeptides encoded in NIAV G gene. (A). Sequence alignment of the DURV (GenBank ADB88756), TUPV (GenBank YP238533), VSINV
(GenBank) and NIAV G proteins showing predicted signal peptides (broken line), transmembrane domains (light shading) and N-glycosylation sites (bold and underlined).
Cysteine residues in the ectodomains (dark shading) are numbered according to the conserved patterns observed in all animal rhabdovirus G proteins [25]. Fully conserved
(n), strongly conserved (:) or weakly conserved (.) amino acids are indicated below the alignment. (B). Deduced amino acid sequence and predicted membrane topology of
the NIAV U2 protein. Predicted transmembrane domains are shaded.
N. Vasilakis et al. / Virology 444 (2013) 80–8984proteins. They are in a region that appears to correspond to the
[s′t] loop of VSINV which is exposed on the G protein surface and
is the location of an antigenic site (Vandepol et al., 1986). NAIV gene
5 encodes the L protein (RNA-dependent RNA polymerase). Also
unique among known rhabdoviruses is that an alternative ORF (U3)
overlaps the N-terminal region of the L ORF by 142 nucleotides. ORF
U3 encodes a highly basic 51-aa polypeptide (6.4 kDa; pI 11.65) of
unknown function. U3 is the ﬁrst ORF that would be detected by
ribosomal scanning on the L mRNA suggesting that it may attenuate
L ORF expression as appears to have been achieved in some other
rhabdoviruses by an overlap with the gene upstream (Tordo and
Poch, 1986) (reviewed in (Walker et al., 2011)).Immunodetection of NIAV proteins
Western immunoblotting was conducted using NIAV MIAF and
control pre-immune serum on NIAV- and mock- infected Vero
cells. At 4 days post infection (dpi), infected whole-cell extracts
contained seven proteins that were not present in mock-infected
cell extracts (Fig. 5). Identiﬁcation of the putative viral proteins
encoded by the genomic nucleotide sequence was based on their
predicted sizes. Since the bands are not individually identiﬁed
(e.g. against protein speciﬁc antisera), they are referred to below as
putative proteins. The largest of these proteins is presumed to be
the L protein, which was predicted to have mass of 243.2 kDa. The
Fig. 5. Immunoblotting of NIAV- and mock-infected BHK cells at four days post
infection using pre-immune mouse serum and mouse ascitic ﬂuid made to NIAV.
Proteins unique to NIAV-infected cells are highlighted by arrows. The molecular
mass landmarks of the Rainbow Molecular Weight Markers (GE Healthcare Life
Sciences) are also indicated.
N. Vasilakis et al. / Virology 444 (2013) 80–89 85second largest is the G protein with a calculated size of 59.9 kDa
(55.9 with the signal peptide removed and unglycosylated). This
protein contains two predicted N-glycosylation sites each adding
approximately 3.5 kDa, which corresponds to the observed size of
approximately 63 kDa (Fig. 5). The third largest protein is the N
protein with a calculated size of 47.4 kDa. The P protein, with a
calculated size of 33.6 kDa is the fourth largest protein. This protein is
usually very immunogenic and reacts strongly with MIAF. However,
its strong charge characteristics and alternating acidic and basic
domains and high proportion of proline residues render its electro-
phoretic characteristics in SDS-gels very inaccurate. Thus, conclusive
identiﬁcation of the P band is difﬁcult using MIAF in the absence of
other information, as either of the two strong bands migrating at
approximately 35 kDa and 45 kDa could be P (Fig. 5). The other may
be a digested fragment of a larger protein (probably G). The M
protein with a calculated size of 18 kDa is the ﬁfth largest protein.
Resolution of the length of the M protein may be unreliable to
determine by SDS-PAGE alone for which size estimations can be
inﬂuenced by structural features. Furthermore, in this MIAF-probed
immunoblot there is no evidence for expression of the putative U1,
U2, or U3 ORFS (Fig. 3A and B), and such evidence will require
additional work. Lastly, the absence of any identiﬁable bands in the
mock-infected cell lysates probed with NIAV-raised MIAF or the
mock- and NIAV-infected cell lysates probed with a control pre-
immune mouse serum, suggests that the additional bands beyond
the 5 that match the predicted sizes of the canonical ORFs (N–P–N–
G–L) in the NIAV genome sequence are due to non-speciﬁc reactivity
of the NIAV-MIAF.
NIAV pathology in mice
Three litters of newborn (1–2 day old) ICR mice with an average
size of 10 pups were inoculated intracerebrally (i.c.) (15–20 μLeach), intraperitoneally (i.p.) (100 μL each) or subcutaneously (s.c.)
(100 μL each) with a stock of Vero-grown NIAV (DakArD 88909)
virus containing ∼106.5 TCID50/mL. The animals were observed
daily for illness and were euthanized when they became severely
ill. By day 3 post-inoculation, all members of the i.c.-inoculated
group were dead or dying. The groups inoculated i.p.- or s.c.
developed signs of illness (lethargy, loss of balance, spastic move-
ments) more slowly, but all were dead or very sick by day 7.
In contrast, adult ICR mice injected i.p. with a 10% brain suspen-
sion from infected newborn mice survived and did show signs of
illness They subsequently developed high levels of CF antibody.
Collectively, these observations suggest that the susceptibility of
mice to NIAV disease is age related.
Sequentially cut thin sections of tissues (brain, lung, liver, spleen
and kidney), collected from three sick i.p.-infected mice, were
stained with hematoxylin and eosin (H&E) for histopathology and
for immunohistochemistry, using a NIAV-speciﬁc polyclonal anti-
body (mouse immune ascitic ﬂuid). Sections of the brain showed
numerous apoptotic bodies in the granular layer of the cerebellum
(Fig. 6A, black arrow). Purkinje cells in many sections were degen-
erating with eosinophilic nuclei and vacuolated cytoplasm (Fig. 6A,
blue arrow). There was perivascular cufﬁng (Fig. 6B) and meningitis
(Fig. 6C). Purkinje cells demonstrated lightly esosinophilic areas in
the cytoplasm most consistent with viral inclusions (Fig. 6D). Immu-
nohistochemistry showed NIAV antigen—positive neurons in the
cerebrum (Fig. 6E) and in the cerebellum including Purkinje cells
(Fig. 6F–G).
Sections of the heart, lung and kidney showed no signiﬁcant
histopathologic changes. Extramedullary hematopoiesis was pre-
sent in the liver and spleen, but this was likely due to the young
age of the animals. No abnormalities were identiﬁed in the liver or
spleen.Conclusions
NIAV is a novel rhabdovirus isolated from phlebotomine
sandﬂies in Senegal. Despite the 20 years that have elapsed since
its isolation, little is known about its host range and epidemiology.
The fact that NIAV has been isolated only once suggests either that
NIAV is rare (in particular, it is unlikely to be associated with
serious disease in humans or livestock, where it would likely have
been tested and found repeatedly), or that the limited epidemio-
logical information and paucity of serosurvey data from that
sparsely populated region of West Africa prevents a comprehen-
sive and accurate assessment of its full geographic range, pre-
valence, and host range. Since the natural host(s) of NAIV beyond
the insect source are unknown, acquisition of human and animal
sera from the same geographic area would offer insights to the
extent of human and veterinary exposure to NIAV infection.
Although the rhabovirus genomes are similar in size, the NIAV
genome organization varies greatly from those of the other
rhabdoviruses with respect to the location of alternative ORFs
potentially encoding accessory proteins. Furthermore, the L pro-
tein phylogeny indicates that NIAV is relatively distantly related to
all other known rhabdoviruses. Analysis of the NIAV genome
indicates several unique aspects among those rhabdoviruses
characterized to date. Speciﬁcally, the M gene contains two
consecutive ORFs whose mechanism of expression is unclear but
similar to the alpha genes (α1 and α2) observed in ephemero-
viruses (reviewed in (Walker et al., 2011)). The G gene contains an
alternative ORF in the N-terminal domain, which was previously
been observed as an overlapping ORF in the C-terminal domain of
Wongabel virus (Gubala et al., 2008). The U2 encoded in the G
gene is a small hydrophobic protein but appears to have a different
structure to those described in other rhabdoviruses. Lastly, the L
Fig. 6. Representative histopathology in brain of newborn mice infected with NIAV. (A) Apoptotic bodies in the granular layer of the cerebellum (black arrow) and
degenerating Purkinje cells with eosinophilic nuclei and vacuolated cytoplasm (blue arrow). (B) Perivascular cufﬁng. (C) Meningitis. (D) Purkinje cells with lightly
easinophilic areas in the cytoplasm most consistent with viral inclusions. (E) NIAV-positive neurons in the cerebrum. ((F)–(G)) NIAV-positive neurons including Purkinje cells
in the cerebellum (F) and (G).
N. Vasilakis et al. / Virology 444 (2013) 80–8986gene also uniquely contains an alternative ORF, which overlaps the
N-terminal region of the L ORF and is the ﬁrst ORF that would be
detected by ribosomal scanning on the L mRNA. Immunodetection
of NIAV-infected cells indicates that some of the predicted novel
proteins may be expressed in infected cells; additional studies are
currently underway which hopefully will elucidate their role and
function in the NIAV replication cycle.The uniqueness of NIAV underscores the diversity of the
Rhabdoviridae and highlights the necessity of further studies to
decipher this diverse and complex family of viruses. The recent
sudden emergence of Bas Congo rhabdovirus from an unknown
source in West Africa and its association with acute hemorrhagic
fever and death (Grard et al., 2012) illustrates the importance of
more comprehensive investigation of uncharacterized viruses.
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Virus source
Niakha virus (DakArD 88909) was isolated from a single pool of
200 mixed sandﬂy species (Phlebotomus duboscqi and Sergento-
myia sp.) collected in light traps near a ground pool at Niakha in
the district of Barkedji in the Ferlo region (15117′N; 14153′W) of
Senegal in March 1992 (Fontenille et al., 1994). The original
isolation was made at the Institut Pasteur de Dakar by intracer-
ebral inoculation of newborn mice with a homogenate of the
sandﬂy pool. Initial serological studies at the Institut Pasteur
de Dakar failed to demonstrate an antigenic relationship of
DakArD88909 with 80 other African arboviruses (Fontenille
et al., 1994); a sample of the virus of unknown passage history
was subsequently sent by Dr. Jean Pierre Digoutte to the World
Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
for further study. Stocks were prepared after 3 passages in Vero
cells. Because NIAV plaques poorly in Vero or BHK cells, quantiﬁ-
cation was based on its cytopathic effect (CPE) in serial 10-fold
dilutions of Vero cells (TCID50).
Cells
Four different cell lines [BHK-21 (baby hamster kidney), Vero
E6 (African green monkey kidney), C6/36 (Aedes albopictus) and
PP-9 (Phlebotomus papatasi)] were used in this study. Each was
originally obtained from the American Type Culture Collection
(ATCC) (Manassas, VA). The PP-9 cell line was initiated by Robert
Tesh and Govind Modi from embryonated eggs of Phlebotomus
papatasi, using techniques described previously (Tesh and Modi,
1983). Monolayer cultures of vertebrate (BHK, Vero E6) or insect
(PP-9) cells in T-25 ﬂasks were inoculated with 100 mL of ∼105.5
TCID50 of a Vero stock. After 2 h of incubation at 37 1C (vertebrate
cells) or 28 1C (insect cells), maintenance medium (Vasilakis et al.,
2013) was added and the culture was maintained at either 37 1C or
28 1C, respectively, and examined daily for evidence of viral
cytopathic effect (CPE).
Transmission electron microscopy
For ultrastructural analysis, ultrathin sections of infected cells
were ﬁxed for at least 1 h in a mixture of 2.5% formaldehyde
prepared from paraformaldehyde powder, and 0.1% glutaralde-
hyde in 0.05 M cacodylate buffer pH 7.3 to which 0.03% picric acid
and 0.03% CaCl2 were added. The monolayers were washed in
0.1 M cacodylate buffer, cells were scraped off and processed
further as a pellet. The pellets were post-ﬁxed in 1% OsO4 in
0.1 M cacodylate buffer pH 7.3 for 1 h, washed with distilled water
and en bloc stained with 2% aqueous uranyl acetate for 20 min at
60 1C. The pellets were dehydrated in ethanol, processed through
propylene oxide and embedded in Poly/Bed 812 (Polysciences,
Warrington, PA). Ultrathin sections were cut on a Leica EM UC7
ultramicrotome (Leica Microsystems, Buffalo Grove, IL), stained
with lead citrate and examined in a Philips 201 transmission
electron microscope at 60 kV.
Preparation for vRNA extraction
BHK cell monolayers, grown to 90% conﬂuence in a T150 ﬂask,
were inoculated with approximately 4 mL of DakArD 88909 virus
harvested from a T25 ﬂask of BHK cells (as described above).
Infected cells were incubated for 1 h with periodic gentle rocking
to facilitate virus adsorption at 37 1C. Following incubation, the
viral inocula were removed, cell monolayers were washed thrice
with PBS to remove unadsorbed virus, 12 mL of culture medium(DMEM-high glucose supplemented with 10% FBS, and 50 mg/mL
penicillin/streptomycin) (Invitrogen, Grand Island, NY) was then
added, and the cells were incubated at 37 1C. Supernatants were
harvested approximately 4 days later when marked CPE was
developed and clariﬁed by low speed centrifugation (2000 g,
10 min at 4 1C). To remove remaining cellular debris, the super-
natant was ﬁltered through a 0.45 μM ﬁlter (EMD Millipore,
Billerica, MA). The clariﬁed supernatant was transferred to a
50 mL tube and treated with a cocktail of DNases [14 U Turbo
DNase (Ambion, Austin, TX), 20 U Benzonase (EMD Millipore,
Billerica, MA) and 20 U RNase One (Promega, Madison, WI)] for
1 h at 37 1C. To further reduce the volume, 24 mL of supernatant
was loaded on top of 8 mL of 30% sucrose (in TEN, pH 7.4) located
on the bottom of a SW28 Beckman UltraClear tube, and centri-
fuged at 150000 g for 4 h at 4 1C. The pellet was resuspended in
250 μL RNase/DNase and protease-free water (Ambion, Austin, TX).
vRNA was then extracted through the Trizol method and resus-
pended in 50 μL RNase/DNase and protease-free water (Ambion,
Austin, TX).
Next generation sequencing
Library construction
Viral RNA (0.1–0.2 μg) quantiﬁed by Nanodrop 1000 spectro-
photometer (Thermo Fisher Scientiﬁc, Pittsburgh, PA), was fragmen-
ted by incubation at 94 1C for 8 min in 19.5 μL of fragmentation
buffer (Illumina 15016648). First and second strand synthesis,
adapter ligation and ampliﬁcation of the library were performed
using the TruSeq RNA Samplec Preparation kit under conditions
prescribed by the manufacturer (Illumina, San Diego, CA). Samples
were tracked using the “index tags” incorporated into the adapters as
deﬁned by the manufacturer.
Sequence analysis
Cluster formation of the library DNA templates was performed
with the Illumina TruSeq PE Cluster Kit v3 and the Illumina cBot
workstation using conditions recommended by the manufacturer.
Paired end 50 base sequencing by synthesis was performed using
Illumina TruSeq SBS kit v3 on an Illumina HiSeq 1000 using
protocols deﬁned by the manufacturer. Cluster density per lane
was 645–980 K/mm2 and post ﬁlter reads ranged from 148 to 178
million per lane. Base call conversion to sequence reads was
performed using CASAVA-1.8.2. Virus assembly was performed
using SeqMan Lasergene software (DNASTAR, Madison, WI).
In certain cases, pre-ﬁltering of reads to remove host sequence
enhanced the assembly process. Assembly was carried out using a
fasta ﬁle of Aedes albopictus sequences to remove host DNA from
the assembly thus reducing the number of contigs present.
Genomic analysis
BLASTX was used to identify sequence homologies with other
viruses. Open reading frames were identiﬁed using MacVectors
version 12.0 (Accelrys, Cary, NC). The presence of conserved
protein domains was determined using the SMART webserver
(Letunic et al., 2012; Schultz et al., 1998).
Nucleotide sequence accession numbers
The complete genome sequence of NIAV was determined in this
study and assigned GenBank accession number KC585008. The
GenBank accession numbers for the genome sequences of other
rhabdoviruses used in the phylogenetic analyses are as follows:
ARV, Adelaide River virus (AFR23540); ABLV, Australian bat lyssa-
virus (NP478343); ARAV, Aravan virus (ABV03822); BEFV, bovine
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(AED98393); COCV, Cocal virus (ACB47438); CPV, coastal plains
virus (ADG86364); DMelSV, Drosophila megalomaster sigmavirus
(YP003126913); DObSV, Drosophila obscura sigmavirus (ACU65444);
DURV, Durham virus (ADB88761); DUVV, Duvenhage virus
(AFK93192); EVEX, Eel virus European X (AFX58972); EBLV1,
European bat lyssavirus 1 (YP001285392); FLAV, Flanders virus
(AAN73288); HIRV, Hirame rhabdovirus (NP919035); IKOV, Ikoma
lyssavirus (AFQ26098); IHNV, infectious hematopoietic necrosis
virus (NP042681); IRKV, Irkut virus (ABV03823); ISFV, Isfahan virus
(CAH17548); JURV, Jurona virus (AEG25349); KHUV, Khujand virus
(ABV03824); KIMV, Kimberley virus (AFR67096); KOTV, Kotonkan
virus (YP006202628); LBV, Lagos bat virus (AFW16650); MARAV,
Maraba virus (AEI52253); MOKV, Mokola virus (YP142354); MOUV,
Moussa virus (ACZ81407); NGAV, Ngaingan virus (YP003518294);
OVRV, Oak Vale virus (AEJ07650); OBOV, Obodhiang virus (YP006-
2000965); OZEV, Ozernoe virus (ACS70797); PRV, Perinet virus
(AEG25355); PFRV, Pike fry rhabdovirus (ACP28002); RABV, rabies
virus (ABN11300); SBV, Shimoni bat virus (ADD84511); SCRV,
Siniperca chuatsi rhabdovirus (YP802942); SHRV, snakehead virus
(NP050585); SVCV, spring viraemia of carp virus (NP116748); TIBV,
Tibrogargan virus (ADG86355); TUPV, Tupaia virus (YP238534);
VSAV, Vesicular stomatitis Alagoas virus (ACB47443); VHSV, viral
hemorrhagic septicemia virus (BAM29126); VSIV, Vesicular Stoma-
titis virus, Indiana (NP041716); VSNJV, Vesicular stomatitis New
Jersey virus (AAA48442); WCBV, West Caucasian bat virus
(ABV03821); and WONV, Wongabel virus (YP002333280). The ICTV
has not yet recognized NIAV as a member species in the family
Rhabdoviridae. As a consequence, its abbreviation should be con-
sidered tentative and subject to approval.
Phylogenetic analysis
The L protein sequence of NIAV was compared with those of 44
other rhabdoviruses downloaded from GenBank. Because of
their excessive sequence divergence to the other rhabdoviruses
including NIAV, members of the Cytorhabdovirus, Novirhabdovirus
and Nucleorhabdovirus genera were excluded from this analysis;
their inclusion resulted in reduced phylogenetic resolution at
internal nodes of the tree, including those relating to NIAV (not
shown). All protein sequences were aligned using MUSCLE (Edgar,
2004) under default settings. Ambiguously aligned regions, which
may negatively effect phylogenetic analysis, were removed using
the Gblocks program (Talavera and Castresana, 2007); this resulted
in a ﬁnal sequence alignment of 1110 amino acid residues. The
phylogenetic relationships among these sequences were deter-
mined using the maximum likelihood (ML) method available in
the PhyML 3.0 program (Guindon et al., 2010), employing the WAG
+Γ model of amino acid substitution and subtree pruning and
regrafting (SPR) branch-swapping. The support for each node was
determined using 1000 bootstrap replicates.
Antigens and immune reagents
Antigens used in complement ﬁxation (CF) tests and for
immunizing animals were prepared from infected newborn mouse
brains. CF antigens were prepared by the sucrose/acetone extrac-
tion method (Clarke and Casals, 1958). Speciﬁc hyperimmune
mouse ascitic ﬂuids were prepared against each of the 24 rhabdo-
viruses listed in Table 1. The immunization schedule consisted of
four intraperitoneal injections given at weekly intervals. Immuno-
gens consisted of 10% suspensions of homogenized infected mouse
brain in PBS mixed with Freund′s adjuvant just prior to inocula-
tion. Sarcoma 180 cells were also given intraperitoneally after the
ﬁnal immunization to induce ascites formation. All animalexperiments were carried out under an animal protocol approved
by the University of Texas Medical Branch IACUC committee.
Serologic testing
Complement ﬁxation tests were conducted using a microassay
described previously (Tesh et al., 1983), using 2 full units of
guinea-pig complement. Titers were recorded as the highest
antibody dilutions giving 3+ or 4+ ﬁxation of complement on a
scale of 0–4+.
Immunoblotting
BHK monolayers were grown to 90% conﬂuency in 25 cm2
tissue culture ﬂasks and were infected with NIAV or were mock
infected as described above. After 2 h, the virus inoculum was
aspirated from the cells, unabsorbed virus was removed by thrice
washing, and fresh media (DMEM) (Invitrogen) supplemented
with 5% fetal bovine serum (FBS) (Atlanta Biologicals, GA) and
1% penicillin/streptomycin (Invitrogen, Grand Island, NY) was
added. Four days after infeciton (p.i.) and incubation at 37 1C,
when marked CPE had developed, the cells were harvested into
cell lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% Triton
X-100). The cell preparations were then treated according to the
Biorad instructions for MiniPROTEAN TGX gel analysis of proteins.
Brieﬂy, 20 μL sample loading buffer containing β-mercaptoethanol
were added to 20 μL aliquots of the cell preparations. Samples
were heated at 95 1C for 10 min, and centrifuged for 1 min at
500 g at 4 1C. Proteins were separated under reducing conditions
on MiniPROTEAN TGX 10–20% Tris-Glycine SDS-PAGE gels, and
were transferred onto Hybond-P PVDF membrane (GE Healthcare
Biosciences, Pittsburgh, PA)) with Transfer Buffer (Biorad, San
Diego, CA) according to the Biorad western blotting transfer
protocol. Membranes were processed by the WesternBreeze©
Chromogenic Immunodetection system (Invitrogen, Grand Island,
NY) following the manufacturer′s protocol. The control pre-
immune mouse serum and polyclonal MIAF raised to NIAV were
used at 1:5000 dilution, whereas the secondary, goat anti-mouse
alkaline phosphatase-conjugated antibody was used as was pre-
diluted by the manufacturer′s WesternBreeze© Chromogenic
Immunodetection system (Invitrogen, Grand Island, NY).
Animal studies
All animal studies were carried out under a protocol approved
by the UTMB Institutional Animal Care and Use Committee.
Approximately 10 pups from each of three litters of newborn
(1–2 day old) ICR mice were inoculated intracerebrally (i.c.),
intraperitoneally (i.p.) or subcutaneously (s.c.) with a Vero stock
of NIAV containing ∼106.5 TCID50/mL. Each of the i.c.-inoculated
pups received 15–20 μL of virus, whereas 100 μL of virus was
injected in each of the i.p. and s.c.-inoculated pups. The animals
were observed daily for illness and were euthanized when they
became seriously ill. Tissues (brain, lung, liver, spleen and kidney)
were collected from three of the sick i.p.-infected mice for
histopathology.
Tissues were ﬁxed in 10% neutral buffered formalin (RICCA
Chemical Company, Arlington, TX) for 24 h and transferred to 70%
ethanol for storage and subsequent embedding in parafﬁn. Sec-
tions (5 μm) were cut and stained by the hematoxylin and eosin
method.
Immunohistochemistry
Slides were deparafﬁnized in Xylene for 15 min, followed by
rehydration in ethanol and ethanol/water mixtures as follows:
N. Vasilakis et al. / Virology 444 (2013) 80–89 89100% ethanol for 9 min, 95% ethanol/5% deionized water for 3 min,
80% ethanol/20% deionized water for 5 min. Antigen retrieval was
facilitated by Protease XXIV (BioGenex, Fremont, CA) incubation
for 5 min at RT, followed by three Tris-buffered saline containing
0.1% Tween 20 (TBST) washes. Further processing of the slides was
according to the VECTASTAINs ABC AP Kit (Burlingame, CA)
protocol. Incubation with a NIAV-speciﬁc hyperimmune mouse
ascitic ﬂuid was performed overnight at 4 1C. Developed slides
were counterstained by the hematoxylin and eosin method and
mounted with DePex (EMS, Hatﬁeld, PA).Acknowledgments
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